Skip to main content
FMCFMC CorporationSell4.3·$11.80+2.52%
Open full analysis

FMC Corporation (FMC) Stock Analysis

Falling Knife setup

SellVALUE-TRAP 1/5Moderate Confidence

Basic Materials · Agricultural Inputs

Sell if holding. Engine safety override at $11.80: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 1.42; Below-average business quality.

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active... Read more

$11.80+32.4% A.UpsideScore 4.3/10#8 of 8 Agricultural Inputs
QualityF-score3 / 9FCF yield1.59%
IncomeYield2.78%(5y avg 4.32%)Payout223.08%at-risk
Stop $10.79Target $15.36(analyst − 10%)A.R:R 2.8:1
Analyst target$17.06+44.6%16 analysts
$15.36our TP
$11.80price
$17.06mean
$26

Sell if holding. Engine safety override at $11.80: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 1.42; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Score 4.3/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, earnings proximity 43d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 202643d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (1.7 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)5.2
Mkt Cap$1.4B
EV/EBITDA17.3
Profit Mgn-72.9%
ROE-78.4%
Rev Growth-4.1%
Beta0.37
Dividend2.78%
Rating analysts22

Quality Signals

Piotroski F3/9

Options Flow

P/C1.42bearish
IV92%elevated
Max Pain$30+154.2% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMProductRynaxypyr® active
    10-K Item 1: 'Rynaxypyr® active (chlorantraniliprole), the world's leading insect control technology – with annual revenues of approximately $0.8 billion in 2025'
  • LOWProductCyazypyr® active
    10-K Item 1: 'Cyazypyr® active (cyantraniliprole), which supports a portfolio of products that generated revenues of approximately $0.4 billion in 2025'
  • MEDIUMSupplierChina and India intermediates
    10-K Item 1A: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'

Material Events(8-K, last 90d)

  • 2026-04-29Item 5.02LOW
    Board director Dirk A. Kempthorne, a member of the FMC board since 2009, passed away. No successor named. The 2026 Incentive Stock Plan was separately approved at the April 28, 2026 Annual Meeting, replacing the 2023 plan.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Revenue shrinking — -4.1% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
1.5
Declining revenue: -4%
Low model confidence on this dimension (33%).

Cyclical trough — margins compressed or negative. Profitability typically recovers with the cycle, but floor fires on current data.static

Roe
0.0
Operating Margin
0.0
Net Margin
0.0
Roa
0.6
Gross Margin
2.4
Moat
2.5
Piotroski F
3.3
Current Ratio
4.9
No competitive moatWeak Piotroski F-Score: 3/9Quality concerns

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Growth Rank
0.0
Value Rank
8.8

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
0.0
Erm
3.5
Dividend Safety
3.5
Earnings Timing
5.0
News Activity
5.0
Earnings History
5.6
Yield trap warning: high yield but unsafe
GatesMomentum 4.4<4.5Death cross (50MA < 200MA)Executive change: officer departure/appointmentA.R:R 2.8 ≥ 1.5Insider activity: OKEARNINGS PROXIMITY 43d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Aggressive
RSI
32 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.72Resistance $13.98

Price Targets

$11
$15
A.Upside+30.2%
A.R:R2.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (1.7 < 4.0)
! momentum at 4.4 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-07-29 (43d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is FMC stock a buy right now?

Sell if holding. Engine safety override at $11.80: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.8:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 1.42; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 32, MACD bearish. Prior stop was $10.79. Score 4.3/10, moderate confidence.

What is the FMC stock price target?

Take-profit target: $15.36 (+32.4% upside). Prior stop was $10.79. Stop-loss: $10.79.

What are the risks of investing in FMC?

Quality below floor (1.7 < 4.0).

Is FMC overvalued or undervalued?

FMC Corporation trades at a P/E of N/A (forward 5.2). TrendMatrix value score: 7.1/10. Verdict: Sell.

What do analysts say about FMC?

22 analysts cover FMC with a consensus score of 3.4/5. Average price target: $17.

What does FMC Corporation do?FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus...

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active ingredients; Rynaxypyr® active generated approximately $0.8 billion in 2025, with Cyazypyr® active brands at approximately $0.4 billion. In February 2026, the Board authorized a strategic review including potential sale of the company.

Related stocks: UAN (CVR Partners, LP) · ICL (ICL Group Ltd.) · SMG (Scotts Miracle-Gro Company (The) · MOS (Mosaic Company (The))
Home Stocks FMC

Latest news

Latest News

Benzinga12h agoProduct
Benzinga29d ago
Benzinga41d agoMerger Acquisition
Benzinga47d agoEarnings
Benzinga47d agoAnalyst
Benzinga47d agoAnalyst
Benzinga47d agoAnalyst
Benzinga49d ago
Benzinga49d agoEarnings
Benzinga49d agoEarnings
Benzinga49d ago
Benzinga49d agoEarnings
Benzinga57d ago
Benzinga57d agoAnalyst
Benzinga58d ago
Benzinga64d ago
Benzinga69d agoAnalyst
Benzinga72d agoProduct